Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6052721 | 1.00 | ALDH1A1 (0.35) | ALDH1A1ATMCHRM2CHRM1CHRM3 | |
| SCHEMBL1327198 | 1.00 | ALDH1A1 (0.35) | ALDH1A1ATMCHRM2CHRM1CHRM3 | |
| SCHEMBL375444 | 0.91 | ALDH1A1 (0.37) | ALDH1A1CHRM2CHRM1CHRM3TSHR | |
| SCHEMBL144302 | 0.91 | ALDH1A1 (0.37) | ALDH1A1CHRM2CHRM1CHRM3TSHR | |
| SCHEMBL12979137 | 0.91 | ALDH1A1 (0.37) | ALDH1A1CHRM2CHRM1CHRM3TSHR | |
| SCHEMBL24411299 | 0.91 | ALDH1A1 (0.37) | ALDH1A1CHRM2CHRM1CHRM3TSHR | |
| SCHEMBL142417 | 0.91 | ALDH1A1 (0.37) | ALDH1A1CHRM2CHRM1CHRM3TSHR | |
| SCHEMBL29013072 | 0.87 | ALDH1A1 (0.40) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 | |
| SCHEMBL29013054 | 0.87 | ALDH1A1 (0.40) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 | |
| SCHEMBL29013043 | 0.87 | ALDH1A1 (0.40) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1729763-A4 | NOVEL BICYCLIC COMPOUNDS AS MODULATORS OF ANDROGEN RECEPTOR FUNCTION AND METHOD | BRISTOL MYERS SQUIBB CO (US) | 2007-10-31 | — | — | EP | disclosed |
| EP-1729763-A2 | NOVEL BICYCLIC COMPOUNDS AS MODULATORS OF ANDROGEN RECEPTOR FUNCTION AND METHOD | Bristol-Myers Squibb Company (US) | 2006-12-13 | — | — | EP | disclosed |
| WO-2005089118-A2 | NOVEL BICYCLIC COMPOUNDS AS MODULATORS OF ANDROGEN RECEPTOR FUNCTION AND METHOD | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-09-29 | — | — | WO | disclosed |